Use of 3,4-diphenyl chroman derivatives in the manufacture of a medicament for lowering serum cholesterol levels and inhibiting smooth muscle cell proliferation, restenosis, endometriosis, and uterine fibroid disease

2000
OA: closed
AI-generated summary by qwen3.7-flash, 2026-09-19

The invention describes methods for treating endometriosis and uterine fibroid disease by administering 3,4-diphenyl chroman derivatives to inhibit smooth muscle cell proliferation.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The present invention provides novel methods of inhibiting smooth muscle cell proliferation, particularly restenosis, in humans, and inhibiting uterine fibroid disease and endometriosis in women comprising administering to a human/woman in need of treatment an effective amount of a compound of formula I wherein R is C1-C6 alkyl, C1-C6 alkoxy, halo, or trifluoromethyl; R1 and R2 each are the same or different C1-C6 alkyl group; n is an integer from 2 to 6; and R3 and R4 each are independently C1-C4 alkyl, or combine to form a substituent selected from the group consisting of pyrrolidino, morpholino, piperidino, piperazino, 4-(C1-C6 alkyl)piperazino, and 4-phenyl-piperazino; or a pharmaceutically acceptable salt thereof.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-26T06:08:41.316361+00:00